Versant Capital Management, Inc Enzo Biochem Inc Transaction History

Versant Capital Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$1.82 - $3.87 $43 - $92	-24 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$2.54 - $4.02 $60 - $96	24 New	24 $0
Q1 2019 Apr 23, 2019	SELL	$2.54 - $4.02 $2,941 - $4,655	-1,158 Closed	0 $0
Q3 2017 Apr 23, 2018	SELL	$10.45 - $11.44 $1,933 - $2,116	-185 Reduced 13.78%	1,158 $12,000
Q2 2017 Apr 23, 2018	SELL	N/A	-287 Reduced 17.61%	1,343 $14,000
Q3 2016 Apr 23, 2018	BUY	N/A	24 Added 1.49%	1,630 $8,000
Q4 2015 Apr 23, 2018	BUY	N/A	1,606	1,606 $7,000

15.5M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $51.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.